Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Reflex Advanced Materials Corp. Announces Amendment of Ruby Graphite Option Agreement
-
FLUENT Corp. to Report Fourth Quarter 2024 Financial Results on April 17, 2025
-
Norwegian Cruise Line Holdings to Hold Conference Call on First Quarter 2025 Financial Results
-
BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
-
Montauk Renewables, Inc. and American Environmental Landfill, Inc. Break Ground on Tulsa RNG Project
-
Arcutis Announces Chief Financial Officer Transition
-
Cornerstone Strategic Investment Fund, Inc. Announces Rights Offering
-
Dime Continues to Execute Growth Plan With Hire of Deposit-Focused Group
-
Alpine Banks of Colorado announces common shareholder dividend
-
GOGL – Notice of 2025 Annual General Meeting
-
CNH announces Chief Financial Officer transition
-
Interpublic Schedules First Quarter 2025 Earnings Release
-
Top Security Executives Recognized at the 2025 PacificNorthwestCISO ORBIE Awards
-
Pilgrim’s Pride Corporation to Host First Quarter Earnings Call on May 1, 2025
-
Announcing new CBH Hearts Across the Valley partner, Hawkins and First Kick-Off Party at local favorite Push & Pour
-
Enact to Host First Quarter 2025 Earnings Call May 1st
-
WCUSD Parent Stella Shakhbazyan Honored as 2025 CABE Parent of the Year
-
Rush Street Interactive Announces First Quarter 2025 Earnings Release Date
-
Cornerstone Total Return Fund, Inc. Announces Rights Offering
-
FutureFuel to Release First Quarter 2025 Financial Results on May 12, 2025
-
Toll Brothers Announces New Luxury Home Community Coming Soon to Reno, Nevada
-
SPS Commerce Announces Date of First Quarter 2025 Financial Results
-
Venus Concept Announces Closing of $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
-
Espey Mfg. & Electronics Corp. Announces Additional New $19.8 Million Contract Award Supporting U.S. Navy’s Virginia and Columbia Class Submarine Programs
-
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
Pool Corporation Announces First Quarter 2025 Earnings Release Date and Conference Call
-
California Water Service Group Schedules 2025 First-Quarter Earnings Results Announcement and Conference Call
-
Protara Therapeutics to Present Interim Analysis from the Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting
-
Rush Enterprises, Inc. Conference Call Advisory for First Quarter 2025 Earnings Results
-
ScottsMiracle-Gro Continues to Advance Consumer and Cannabis Strategies
-
Itron to Announce First Quarter Results on May 1, 2025
-
Exponent to Announce First Quarter of Fiscal Year 2025 Results and Host Quarterly Conference Call on May 1, 2025
-
Altus Group to Hold Annual Meeting of Shareholders on May 7 and Release Q1 2025 Financial Results on May 8; Announces Other Upcoming Investor Events
-
Astera Labs Announces Conference Call to Review First Quarter 2025 Financial Results
-
Varonis Announces Date of First Quarter 2025 Financial Results
-
Vishay Precision Group Announces Date for Its First Quarter Fiscal 2025 Earnings Conference Call
-
ACM Research Receives 2025 3D InCites Technology Enablement Award
-
Root, Inc. Schedules Conference Call to Discuss First Quarter 2025 Financial Results
-
BrightSpring Health Services, Inc. to Announce First Quarter 2025 Financial Results on May 2, 2025
-
Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025
-
SFL - Notice of Annual General Meeting 2025
-
AvePoint to Announce First Quarter 2025 Financial Results on May 8
-
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
-
AppFolio, Inc. Announces Date of First Quarter 2025 Financial Results Conference Call
-
Folia Health Expands Its Rare Renal Disease Research with a New C3G Study to Assess Real-World Disease Impact
-
Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings
-
MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences
-
FormFactor to Announce First Quarter 2025 Financial Results on April 30th
-
Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer
-
MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences

